CSI Market
Sign In | Register

Scpharmaceuticals Inc (SCPH) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access SCPH Annual Cash Flow →
Observing cash flow movements over recent quarters helps explain how Scpharmaceuticals Inc adapts cash usage as operating conditions change.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2025)
6 Months 		(Mar 31 2025) (Dec 31 2024) (Sep 30 2024) (Jun 30 2024)
Operating Activities
Income-37.77
Depreciation & amortization0.01
Amortization of Other Assets0.00
Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-0.81
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation2.81
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Taxes Paid0.12
Conversion Of Stock Amount Converted-
Allowance For Excess Damaged And Obsolete Inventory-
Fair Value Adjustment To Derivative Liability-
Fair Value Adjustment To Term Loan-0.15
Fair Value Adjustment To Revenue Purchase And Sale Liability4.31
Operating Lease Right Of Use Asset Amortization Expense0.12
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-7.69
Increase (Decrease) in Accounts Payable and Accrued Liabilities5.10
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.67
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.01
Discontinued operations0.00
Net Cash flow from Operating Activities-33.25
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Proceeds from Maturities, Prepayments and Calls of Short-term Investments0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.32
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Issuance Of Debt Net Of Issuance Costs-
Payments For Repurchase Of Restricted Stock-
Proceeds From Exercise Of Vested Stock Options-
Proceeds From Follow On Offering Of Stock-
Payment Of Term Loan Exit Fee-
Payment Of Term Loan Final Fee-
Proceeds From Revenue Participation Agreement Net-
Payment On Revenue Purchase And Sale Liability-1.91
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-1.60
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-33.25
Total Cash Flow-34.85
4 historic quarters locked

Sign in to unlock the full Scpharmaceuticals Inc cash flow history.

Sign In Create Free Account

About Scpharmaceuticals Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-25-175437

Figures are derived from filed reports and may be restated. Historical data is subject to revision.